Press Releases on May 4, 2023 - EIN Presswire - Press Release Distribution Service

Published on May 4, 2023 - 20:05 GMT

CNB Financial Corporation Announces Quarterly Dividend For Series A Preferred Stock and Related Depositary Shares Distribution

CLEARFIELD, Pa., May 04, 2023 (GLOBE NEWSWIRE) -- The Board of Directors of CNB Financial Corporation (Nasdaq: CCNE) (the "Corporation") has announced the declaration of a quarterly cash dividend of $0.4453125 per depositary share, resulting from …

Distribution channels: Banking, Finance & Investment Industry ...

Published on May 4, 2023 - 20:05 GMT

Hudson Global to Report First Quarter 2023 Financial Results on May 10th

OLD GREENWICH, Conn., May 04, 2023 (GLOBE NEWSWIRE) -- Hudson Global, Inc. (Nasdaq: HSON), a leading global talent solutions company, will issue first quarter financial results for the period ended March 31, 2023, before the market opens on Wednesday, May …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on May 4, 2023 - 20:05 GMT

Crinetics Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

Phase 3 PATHFNDR-1 study topline data expected in 3Q 2023 Phase 3 PATHFNDR-2 study topline data expected in 1Q 2024 and enrollment target increased to up to 98 per prespecified protocol criteria Paltusotine’s Phase 2 study in carcinoid syndrome on track …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 4, 2023 - 20:05 GMT

Aligos Therapeutics Reports Recent Business Progress and First Quarter 2023 Financial Results

SOUTH SAN FRANCISCO, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 4, 2023 - 20:05 GMT

Cocrystal Pharma Presents New Data from its CC-42344 Phase 1 Influenza A Study at the 7th Annual ISIRV Antiviral Group Conference

BOTHELL, Wash., May 04, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) announces that new data from its CC-42344 Phase 1 influenza A Study was presented today by Sam Lee, Ph.D., President and co-CEO, at the 7th …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 4, 2023 - 20:05 GMT

Helius Medical Technologies, Inc. to Release First Quarter 2023 Financial Results on May 11, 2023

NEWTOWN, Pa., May 04, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 4, 2023 - 20:05 GMT

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2023

Two phase 1 clinical trials recruiting patients at 14 sites across the US; nine sites for LYL797, a ROR-1-targeted chimeric antigen receptor T cell (CAR-T) product candidate, and five sites for LYL845, a tumor infiltrating lymphocyte (TIL) product …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 4, 2023 - 20:05 GMT

Ventyx Biosciences to Report First Quarter 2023 Financial Results on May 11, 2023

ENCINITAS, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory diseases with significant …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 4, 2023 - 20:05 GMT

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass., May 04, 2023 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the “Company” or “Viridian”), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, …

Distribution channels: Technology ...

Published on May 4, 2023 - 20:05 GMT

Altair Announces First Quarter 2023 Financial Results

TROY, Mich., May 04, 2023 (GLOBE NEWSWIRE) -- Altair (Nasdaq: ALTR), a global leader in computational science and artificial intelligence, today released its financial results for the first quarter ended March 31, 2023. “Altair had a very strong start to …

Distribution channels: Business & Economy, IT Industry ...

Published on May 4, 2023 - 20:05 GMT

Clover Health to Present at Bank of America 2023 Healthcare Conference on May 11, 2023

FRANKLIN, Tenn., May 04, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CFO, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 4, 2023 - 20:05 GMT

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., May 04, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 4, 2023 - 20:05 GMT

Alector Reports First Quarter 2023 Financial Results and Provides Business Update

On track to engage with regulatory authorities on the pivotal Phase 3 INFRONT-3 clinical trial of latozinemab in mid-2023; targeting data readout in early 2025 Plan to present additional results from the entire FTD-C9orf72 cohort in the INFRONT-2 Phase 2 …

Distribution channels: Business & Economy ...

Published on May 4, 2023 - 20:05 GMT

Marathon Digital Holdings Schedules Conference Call for First Quarter 2023 Financial Results

FORT LAUDERDALE, Fla., May 04, 2023 (GLOBE NEWSWIRE) -- Marathon Digital Holdings, Inc. (NASDAQ:MARA) ("Marathon" or "Company"), a leader in supporting and securing the Bitcoin ecosystem, will hold a webcast and conference call on …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on May 4, 2023 - 20:05 GMT

Jamf Announces CEO Transition Plan, Appointing John Strosahl as Chief Executive Officer

MINNEAPOLIS, May 04, 2023 (GLOBE NEWSWIRE) -- Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, announced today it has appointed John Strosahl as Chief Executive Officer, effective September 2, 2023. Mr. Strosahl will succeed Jamf’s …

Distribution channels: Companies, Technology ...

Published on May 4, 2023 - 20:05 GMT

iRhythm Technologies Announces First Quarter 2023 Financial Results

SAN FRANCISCO, May 04, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today reported financial results for the three …

Distribution channels: Business & Economy, Technology ...

Published on May 4, 2023 - 20:05 GMT

Onconova Therapeutics to Provide Corporate Update and Announce First Quarter 2023 Financial Results on May 15, 2023

NEWTOWN, Pa., May 04, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova” or “the Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 4, 2023 - 20:05 GMT

Immuneering Reports First Quarter 2023 Financial Results and Provides Business Updates

- Positive Initial Phase 1 Pharmacokinetic, Pharmacodynamic and Safety Data for IMM-1-104 Universal-RAS Program presented at American Association for Cancer Research (AACR) annual meeting - -First demonstration of novel deep cyclic inhibition mechanism in …

Distribution channels: Business & Economy, Technology ...

Published on May 4, 2023 - 20:05 GMT

OrthoPediatrics Corp. Announce Launch of RESPONSE™ Power Scoliosis System

WARSAW, Ind., May 04, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, today announced the launch of their new Power System for …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on May 4, 2023 - 20:05 GMT

SIGA Reports Financial Results for Three Months Ended March 31, 2023

NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three months ended March 31, 2023. “First quarter product revenues primarily …

Distribution channels: Business & Economy, Technology ...